Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Salymint

Approved

STANDARD

Salymint

Zhejiang Jingwei Pharmaceutical Co., Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: e2992bc1478f274e
Company: Zhejiang Jingwei Pharmaceutical Co., Ltd.
Type: Standard

Approval Details

Approval Id: e2992bc1478f274e
Drug Approval Philippines Name: Salymint
Product Name: Salymint
Registration Number: HRP-289
Brand Name: Salymint
Generic Name: Menthol + Methyl Salicylate
Dosage Form: Cream
Dosage Strength: 56 mg (5.6 %w/w) + 110 mg (11% w/w) per g
Manufacturer: Zhejiang Jingwei Pharmaceutical Co., Ltd.
Importer: Aglobal Care, Inc.
Distributor: Aglobal Care, Inc.
Issuance Date: 25 September 2023
Expiry Date: 05 November 2028
Pharmacologic Category: Counterirritant
Classification: Household Remedy (HR)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

e2992bc1478f274e

Type

Standard

Back to Philippines FDA Approvals

Salymint - Philippines FDA Drug Approval Details